Investigational Drug Information for Sabarubicin
✉ Email this page to a colleague
What is the drug development status for Sabarubicin?
Sabarubicin is an investigational drug.
There have been 3 clinical trials for Sabarubicin.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2001.
The most common disease conditions in clinical trials are Neoplasms, Testicular Neoplasms, and Neoplasms, Germ Cell and Embryonal. The leading clinical trial sponsors are European Organisation for Research and Treatment of Cancer - EORTC and [disabled in preview].
Summary for Sabarubicin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 39 |
| WIPO Patent Applications | 55 |
| Japanese Patent Applications | 20 |
| Clinical Trial Progress | Phase 2 (2001-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Sabarubicin
| Title | Sponsor | Phase |
|---|---|---|
| MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| MEN-10755 in Treating Patients With Solid Tumors | European Organisation for Research and Treatment of Cancer - EORTC | Phase 1 |
| MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | European Organisation for Research and Treatment of Cancer - EORTC | Phase 1 |
Clinical Trial Summary for Sabarubicin
Top disease conditions for Sabarubicin
Top clinical trial sponsors for Sabarubicin
US Patents for Sabarubicin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
